Recon: Amid regulatory shakeups, drugmakers schedule meeting with Trump next week; FDA clears GSK’s meningococcal combo jab
ReconJason Scott
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)